The development of miltefosine for the treatment of visceral and cutaneous Leishmaniasis

被引：5

作者：

Richard D. Pearson

机构：

来源：

关键词：

Visceral Leishmaniasis; Leishmaniasis; Motion Sickness; Cutaneous Leishmaniasis; Leishmania Species;

D O I：

10.1007/s11908-003-0063-1

中图分类号：

学科分类号：

摘要：

引用

页码：41 / 42

页数：1

共 22 条

[1]

Croft SL(1987)The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani Biochem Pharmacol 36 2633-2636

[2]

Neal RL(1999)Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis N Engl J Med 341 1795-1800

[3]

Pendergast W(1998)Trial of oral miltefosine for visceral leishmaniasis Lancet 352 1821-1823

[4]

Chan JH(1999)Oral treatment of visceral leishmaniasis with miltefosine Ann Trop Med Parasitol 93 589-597

[5]

Jha TK(2000)Short-course of oral miltefosine for treatment of visceral leishmaniasis Clin Infect Dis 31 1110-1113

[6]

Sundar S(2001)Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent Clin Infect Dis 33 E57-E61

[7]

Thakur CP(2002)Oral miltefosine for Indian visceral leishmaniasis N Engl J Med 347 1739-1746

[8]

Sundar S(undefined)undefined undefined undefined undefined-undefined

[9]

Rosenkaimer F(undefined)undefined undefined undefined undefined-undefined

[10]

Makharia MK(undefined)undefined undefined undefined undefined-undefined